RxDoctor Payments Data

Alan Bloch, DPM

Primary Podiatric Medicine · Northville, MINPI 1477551893

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations.

$2,344in general payments, 2019–2025

Across 70 payments — averaging $33.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$373
  • Aroa Biosurgery Incorporated$296
  • Paragon 28, Inc.$270
  • Johnson & Johnson$127
  • Fusion Orthopedics USA, LLC$116
  • Treace Medical Concepts, Inc.$102
  • plus $1K from 27 others

What the payments were for

  • Food & beverage$2,344100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,344 in reported general payments places this provider in the 75th percentile of 24 primary podiatric medicine providers in Michigan.

See all primary podiatric medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$87,295
Medicare patients
234
Services billed
1,335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin22$594
Gabapentin37$345
Ketoconazole20$321
Allopurinol18$181
Terbinafine Hcl14$120
Triamcinolone Acetonide14$76
Meloxicam15$38

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Northville

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →